GlassScriptPhysician profile
Elena Levy
NPI 1629179569
$5,362.44
in general payments reported to CMS, 2019-2025
18 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,240 · 2022: $957 · 2023: $748 · 2024: $1,196 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,113 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,112.90 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,030.44 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $771.24 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $575.70 | 2021-2025 | Nucala |
| Optinose US, INC. | $555.99 | 2021-2025 | |
| Alk-Abello, INC | $291.93 | 2021-2025 | Odactra, Grastek, Ragwitek |
| Ars Pharmaceuticals Operations, INC. | $145.03 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $130.01 | 2023-2024 | Ryaltris |
| Abbvie INC. | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Leo Pharma INC. | $123.72 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $104.00 | 2021 | |
| Kaleo, INC. | $74.40 | 2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $72.39 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $67.82 | 2025 | |
| Amgen INC. | $64.99 | 2021-2023 | Tezspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $52.99 | 2024 | |
| Grifols USA, LLC | $32.72 | 2025 | Xembify |
| Phathom Pharmaceuticals, INC. | $19.07 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.